CSR

Medium-term Targets and Progress Status

Corporate Governance

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2017 Results in FY2017 Evaluation Action plan for FY2018
Strengthen corporate governance Evaluate the measures that have been newly taken, and continue to step up corporate governance Made progress in the efforts for enhancing the corporate governance, for example, reviewed the operation of the Board of Directors from the viewpoint of improvement of the boardfs efficiency › Further enhance the corporate governance by, for example, leveraging the new viewpoints of outside directors who have experience of running companies

Innovative Pharmaceutical Products

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2017 Results in FY2017 Evaluation Action plan for FY2018
Research and develop innovative pharmaceutical products Develop drugs through unique methods, carry out speedy clinical development, and conduct aggressive licensing Signed four drug discovery partnership agreements aiming to create innovative new drugs, and received approval of additional indications for two products, and introduced five compounds and derived one compound › Continue to develop drugs through unique methods, carry out speedy clinical development, and conduct aggressive licensing
Conduct appropriate marketing Use the latest data in providing information mainly on safety and other issues in appropriate ways Sped up process for gathering and conveying information on safety and proper usage, provided online information on treatment and pharmaceuticals › Promote the provision of appropriate information and safety information according to the medical system of each medical district
Supply products to global markets Step up the production of the ONO brand products aimed at Asian markets to strengthen the system for stable supply Stepped up the production of the ONO brand products aimed at Asian markets › Step up the production by adding a production base of pharmaceutical substance for the ONO brand products aimed at Asian markets
Ensure stable supply of antibody products Add a domestic storage site for pharmaceutical substances of antibody products to strengthen the system for stable supply Added a domestic storage site for pharmaceutical substances of antibody products in the Osaka area › Add one more plant to produce antibody products in Japan

Human Resources and Human Rights

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2017 Results in FY2017 Evaluation Action plan for FY2018
Strengthen the human resource development system Hiring
Continuously hire diverse human resources in response to changes in the social environment

Revised the hiring process to effectively secure new graduates and mid-career recruits

›

Continue to hire diverse human resources in response to changes in the social environment
Education/Training
Provide employees with opportunities for their growth and work to improve education and training programs to make them more effective

Provided employees with opportunities for their growth, and conducted training that was useful in fostering human resources

›

Continue to provide employees with opportunities for their growth, work to improve education and training programs to make them more effective, and develop a system to support such improvement
Self-learning
Work to enrich the correspondence courses and promote self-learning

Enriched correspondence courses and established the system to encourage self-learning

›

Continue to work to enrich the correspondence courses and promote self-learning
Respect human rights Operate the personnel system based on current human resource policy, and verify this system Established and operated the system based on current human resource policy › Continue to operate and review the personnel system based on current human resource policy
Hold compliance training to help prevent harassment and other noncompliance We prohibited harassment and held compliance training aimed at preventing harassment. › Continue to hold compliance training to help prevent harassment and other noncompliance

The Environment

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2017 Results in FY2017 Evaluation Action plan for FY2018
Reduce CO2 emissions by 23% from the FY2005 level in FY2020
Note: Covers production and research sites
Incorporate highly energy-efficient equipment when upgrading equipment, and continue strict air conditioner control in order to improve energy efficiency and reduce CO2 emissions As a result of introduction of energy-efficient equipment and thorough energy management, CO2 emissions decreased by 10.1% over FY2005 ¢ Incorporate highly energy-efficient equipment when introducing new equipment and upgrading equipment, and continue strict air conditioner control in order to improve energy efficiency and reduce CO2 emissions
Reduce the amount of PRTR Class I designated chemical substances released into the environment Maintain the volume of chemicals handled at the current level, and continue to work to reduce their discharge into the atmosphere Periodic replacement of exhaust air filters reduced chemicals discharged into the atmosphere › Maintain the volume of chemicals handled at the current level, and continue to work to reduce their discharge into the atmosphere
Maintain FY2020 waste landfilled at the FY2015 level.
Note: Covers production and research sites
Set a new target of maintaining FY2020 waste landfilled at the FY2015 level, and work to maintain and continue proper management of waste Increased the amount of waste landfilled by 44.4% in FY2017 compared to that in FY2015 because of a temporary increase due to renovation work on the investigational drug-related facilities carried out at the Joto Plant ~ Reduce FY2020 waste landfilled to or below the FY2015 level
Prevent environmental accidents and complaints from local communities on an ongoing basis Continue proper management of pollutants with the goal of maintaining our record of zero complaints from local communities There were neither violations of emission standards nor complaints from local communities › Continue proper management of pollutants with the goal of maintaining our record of zero complaints from local communities
Comply with guidelines issued by the Ministry of the Environment of Japan Continue to reduce environmental impact in order to improve environmental efficiency The environmental efficiency indicator improved by 45.0 points compared to that in FY2005 due to the increase in sales although our waste temporarily increased from the previous year due to renovation work on the investigational drug-related facilities carried out at the Joto Plant › Continue to reduce environmental impact in order to improve environmental efficiency
Beautify local communities, prevent workplace accidents involving employee injury Take part in environmental protection activities and community action programs. Continue to educate employees Major bases such as production sites and research institutes took part in community clean-ups and firefighting activities. Took part in the cityfs programs and educated employees on workplace safety › Implement various social contribution activities including participation in environmental protection activities and programs of local communities
Also, continue education and other activities to raise awareness of employees to give first priority to the safety and health of employees

Fair Operating Practices

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2016 Results in FY2016 Evaluation Action plan for FY2017
Promote CSR procurement Obtain consent to our new conditions for transactions from suppliers and have them conclude contracts under the conditions Obtained consent to our new conditions for transactions from suppliers and had them conclude contracts under the conditions › Continue to obtain consent to our conditions for transactions from suppliers and to have them conclude contracts under the conditions
Conduct activities to eliminate noncompliance Promote understanding and raise awareness among employees through training and other measures, and continue organizational promotion activities to prevent occurrence or recurrence of noncompliance Set up the months to enhance the promotion of compliance (from October to December) and the month to promote the understanding of the codes (November), and tried to improve employeesf familiarity with and understanding thorough lectures by leaders, etc. › Continue to promote understanding and raise awareness among employees through training and other measures, and continue organizational promotion activities to prevent occurrence or recurrence of noncompliance

Society

Evaluation criteria@›FAchieved,@¢FMostly achieved@~FNot achieved

Medium-term targets Plan for FY2017 Results in FY2017 Evaluation Action plan for FY2018
Actively promote community involvement as a corporate citizen Step up the medical treatment and health initiative and projects to contribute locally Continued the medical treatment and health initiative and projects to contribute locally including cleanup activities, disaster prevention activities, and class at neighboring schools › Continue to step up the medical treatment and health initiative and projects to contribute locally
Continue academic support activities through endowed courses Provided academic support through approximately 40 endowed courses nationwide › Continue academic support activities through endowed courses
Support patients and their families Support lectures and other events sponsored by patient organizations Supported events such as lectures on topics such as diabetes, dementia, and cancer › Continue to support lectures and other events sponsored by patient organizations
Continue to provide medical information online, and renew the pages for medical professionals on the ONO Oncology website Expanded the contents on sites including ONO Medical Navi and a website specializing in dementia, and renewed the pages for medical professionals on the ONO Oncology website › Continue to provide medical information online, and enhance the contents
Enrich the content to educate patients about diseases such as cancer, and renew the pages for the public on the ONO Oncology website Renewed online content to introduce diseases such as diabetes, dementia, urinary organs, and cancer to raise awareness of the diseases. And, renewed the pages for the public on the ONO Oncology website › Continue to enrich the content to educate patients about diseases such as cancer; and complete the renewal of the pages for the public on the ONO Oncology website